Oculogyx, a leading innovator in artificial intelligence applications for eye care, is proud to announce its official launch.
Oculogyx is set to revolutionize the field of optometry and ophthalmology with AI-driven solutions, including advanced image analysis, an ophthalmic study guide, AI-powered scribe services, and intelligent practice agents.
With the increasing demand for efficiency and accuracy in eye care, Oculogyx harnesses the power of artificial intelligence to assist eye care professionals in streamlining workflows, improving diagnostic accuracy, and enhancing patient care.
“Oculogyx was founded with a vision to empower eye care providers through AI technology,” said David Schanzlin, MD, ophthalmologist and founder of Oculogyx. “Our suite of AI-powered tools is designed to seamlessly integrate with existing clinical workflows, allowing physicians to focus more on patient care and less on administrative burdens.”
Key Oculogyx Offerings:
GenA Eye: A specialized knowledge repository, providing immediate answers to clinical queries. Doctors can navigate information with ease and ensure they remain at the forefront of ophthalmic advancements without sacrificing patient time.
GenA Eye Powered Image Analysis: Enhances diagnostic precision by leveraging advanced machine learning algorithms to assist in interpreting ophthalmic images.
GenA Eye Scribe: A cutting-edge scribe solution that automates documentation, reducing charting time and administrative workload.
GenA Eye Ophthalmic Study Guide: A comprehensive AI-driven resource to support learning and decision-making for eye care professionals.
GenA Eye Practice Agents: Intelligent AI assistants that optimize practice management, improving operational efficiency.
The launch of Oculogyx marks a significant advancement in AI applications for eye care, positioning the company at the forefront of medical innovation.
About the founder
David Schanzlin, MD is a renowned ophthalmologist and innovator in the field of eye care. With decades of experience in corneal surgery and refractive procedures, Dr. Schanzlin has been a pioneer in advancing ophthalmic technologies.
His extensive research and contributions to the field have earned him international recognition. As the founder of Oculogyx, Dr. Schanzlin brings his expertise and visionary leadership to develop AI-driven solutions that enhance patient outcomes and streamline clinical workflows. His commitment to innovation and excellence continues to shape the future of ophthalmology.
About Oculogyx
Oculogyx is a pioneering AI company dedicated to enhancing eye care through advanced technology. By integrating AI into everyday practice, Oculogyx aims to support eye care professionals with innovative tools that improve diagnostics, patient outcomes, and operational efficiency.